Valion Bio VBIO Income Statement (2021-2026)

NASDAQ VBIO
$2.51 -0.29 (-10.36%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Valion Bio Quarterly Income Statement

Periods 21 quarters
Latest Jun 2026

Valion Bio reported net income of -$7.10M for the quarter ended Jun 2026. This income statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
0.27M0.28M0.39M0.43M0.53M0.48M0.41M0.38M0.16M0.28M0.36M0.33M0.14M0.13M0.18M0.07M0.09M0.15M
Cost of RevenueCost of Rev
0.30M0.30M0.39M0.36M0.40M0.41M0.36M0.26M0.10M0.17M0.35M0.17M0.11M0.08M0.42M0.02M0.03M0.29M
Gross Profit
-0.03M-0.03M-0.00M0.07M0.12M0.06M0.04M0.11M0.06M0.11M0.01M0.17M0.03M0.04M-0.24M0.05M0.05M-0.14M
Operating items
Research & DevelopmentR&D
0.19M0.17M0.31M0.40M0.50M0.40M0.43M0.49M0.47M0.34M0.36M0.26M0.30M0.42M0.33M0.34M0.66M0.86M1.28M2.70M
Selling, General & AdministrativeSG&A
0.48M0.58M1.28M1.23M1.52M1.76M1.36M1.28M1.27M1.05M1.15M0.89M0.79M0.82M0.67M1.04M1.02M1.06M1.75M3.72M
Other Operating ExpensesOther Opex
0.34M0.45M0.69M0.68M1.12M0.49M0.50M0.46M0.45M0.48M0.73M0.51M0.21M0.23M-0.95M0.18M0.41M-1.02M
Operating ExpensesOpex
1.02M1.20M2.29M2.31M3.14M2.65M2.30M2.23M2.19M1.87M2.25M1.65M1.30M1.48M0.06M1.56M1.68M2.34M2.02M6.42M
Operating IncomeOp. Inc
-1.05M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-0.30M-1.51M-1.68M-2.48M-1.98M-6.42M
EBIT
-1.05M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-0.30M-1.51M-1.68M-2.48M-1.98M-6.42M
Non-operating items
Non Operating Interest Expenses
0.22M0.69M
Non Operating Investment IncomeNon-Op. Investment Inc.
-0.12M
Interest & Investment IncomeInt & Inv Inc
0.01M0.00M0.00M0.01M0.01M
Other Non Operating IncomeOther Non Op Inc.
0.16M0.08M-1.79M-0.00M0.06M-0.06M0.05M
Non Operating IncomeNon Op. Inc.
-0.04M-1.09M-1.43M0.00M0.00M-0.06M0.01M0.00M0.00M-0.11M0.01M-0.63M
Net income details
EBT
-1.28M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-0.29M-1.51M-1.68M-2.48M-1.96M-7.10M
Profit After TaxPAT
-1.28M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-0.29M-1.51M-1.68M-2.48M-1.96M-7.10M
Income from Continuing OperationsIncome (Continuing)
-1.28M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-0.29M-1.51M-1.68M-2.48M-1.96M-7.06M
Income from Discontinued OperationsIncome (Discontinued)
-0.26M-0.05M
Consolidated Net IncomeConsol Net Inc.
-1.28M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-0.29M-1.51M-1.93M-2.48M-1.96M-7.10M
Income towards Parent CompanyParent Net Inc
-1.09M-2.32M-3.72M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-1.50M-1.50M-1.93M-2.60M-2.87M-7.10M
Preferred Dividend PaymentsPref Dividends
0.00M0.25M
Net Income towards Common StockholdersNet Income
-1.09M-2.32M-3.72M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-1.50M-1.50M-1.93M-2.60M-2.87M-7.35M
Additional items
EPS (Basic)
-11.52-22.50-26.65-5.76-7.84-667.53-583.31-262.89-179.01-36.98-70.71-25.23-7.89-5.78-130.49-62.96-54.81-49.14-62.11-54.36
EPS (Diluted)
-11.52-22.50-26.65-5.76-7.84-6.68-5.84-262.89-179.01-36.98-70.71-25.23-7.89-5.78-130.49-62.96-54.81-73.64-81.44-208.47
Shares Outstanding
0.09M0.10M0.14M0.39M0.38M0.00M0.00M0.01M0.01M0.05M0.03M0.06M0.16M0.25M0.01M0.02M0.04M0.05M0.05M0.14M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.09M0.10M0.14M0.39M0.38M0.39M0.39M0.01M0.01M0.05M0.03M0.06M0.16M0.25M0.01M0.02M0.04M0.04M0.04M0.04M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.09M0.11M0.14M0.39M0.38M0.00M0.00M0.01M0.01M0.05M0.03M0.06M0.16M0.25M0.01M0.03M0.04M0.05M0.05M0.14M
EBITDA
-1.05M-1.23M-2.29M-2.24M-3.02M-2.58M-2.25M-2.11M-2.12M-1.76M-2.24M-1.48M-1.26M-1.43M-0.30M-1.50M-1.68M-2.48M-1.97M-6.07M
Interest ExpensesInt Expense
0.22M0.69M

Valion Bio Income Statement API

Pull Valion Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VBIO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY